Atlas Trials

A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Clinical trial NCT04784533 · COMPLETED

Trial details

NCT number
NCT04784533
Sponsor
Concert Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2021-02-26
Primary completion
2023-05-16
Enrollment
317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.